The seventh batch of national procurement is opening bids, which affects the hearts of countless pharmaceutical people, and how generic drug companies can survive the current difficult period

The seventh batch of national procurement is opening bids, which has touched the hearts

The seventh batch of national procurement is opening bids, which has touched the hearts

How do generic drug companies survive the current difficult times? The author believes that the firm development of the market outside the standard is the only choice

01 What is an off-label market? 01 What is an off-label market? 01 What is an off-label market?

The out-of-label market is a new word

Let's carefully analyze the specific connotation

The author once suggested that the reference to "three terminals and six major markets" should be gradually changed to "four terminals and nine major markets"

The author once suggested that the reference to "three terminals and six major markets" should be gradually changed to "four terminals and nine major markets"

The first terminal, the public hospital market

The first terminal, the public hospital market

The second terminal, the pharmacy market

Third terminal: public primary medical institutions
.
Including community health service centers and township health centers;

Third terminal: public primary medical institutions
.
Including community health service centers and township health centers;

The fourth terminal: the private medical institution market
.
These include private hospitals, private clinics and village clinics (non-public parts
).

The fourth terminal: the private medical institution market
.
These include private hospitals, private clinics and village clinics (non-public parts
).

Compared with the previous one, in addition to adding a market and three terminals, the online pharmacy of the second terminal is modified to an "online sales terminal", which caters to the current hot online sales channels for drugs, which is more rigorous and scientific, and more realistic
.

Compared with the previous one, in addition to adding a market and three terminals, the online pharmacy of the second terminal is modified to an "online sales terminal", which caters to the current hot online sales channels for drugs, which is more rigorous and scientific, and more realistic
.

Among them, the first and third terminals are all in-standard markets
.

Among them, the first and third terminals are all in-standard markets
.

The second terminal includes both in-standard and out-of-standard markets
.
With the implementation of the policy of medical insurance dual channel and the opening of online medical insurance payment, whether it is physical pharmacies or online drug sales, part of it is paid by
medical insurance.
In fact, in recent batches of national procurement, some medical insurance pharmacies are involved in the reporting.

But on the whole, the second terminal is still dominated by the out-of-standard market, and the off-standard market occupies a large proportion
.

The second terminal includes both in-standard and out-of-standard markets
.
With the implementation of the policy of medical insurance dual channel and the opening of online medical insurance payment, whether it is physical pharmacies or online drug sales, part of it is paid by
medical insurance.
In fact, in recent batches of national procurement, some medical insurance pharmacies are involved in the reporting.

But on the whole, the second terminal is still dominated by the out-of-standard market, and the off-standard market occupies a large proportion
.

The fourth terminal is also the coexistence of the intra-standard and out-of-standard market, mainly
the off-standard market.

The fourth terminal is also the coexistence of the intra-standard and out-of-standard market, mainly
the off-standard market.

In recent years, the trend of drug sales flowing to the out-of-standard market has become more and more obvious
.
In the past, it was said that it flowed to the out-of-hospital market, and since not all hospitals enjoy medical insurance reimbursement, it was more accurate
to use the out-of-standard market.

In recent years, the trend of drug sales flowing to the out-of-standard market has become more and more obvious
.
In the past, it was said that it flowed to the out-of-hospital market, and since not all hospitals enjoy medical insurance reimbursement, it was more accurate
to use the out-of-standard market.

It is not difficult to see that in the four major terminals and nine major markets, the share of the out-of-standard market is high
.

It is not difficult to see that in the four major terminals and nine major markets, the share of the out-of-standard market is high
.

02 Why do we need to expand the out-of-standard market?

02 Why do we need to expand the out-of-standard market? 02 Why do we need to expand the out-of-standard market? 02 Why do we need to expand the out-of-standard market?

You may still have the impression that almost twenty years ago, the sales of the first terminal accounted for nearly 80% of the four terminals, and now, it is expected to fall below
60%.
This is mainly related to the change of people's drug consumption habits and the epidemic situation caused by the guidance of pharmaceutical policies, the rise of new terminals, and the development of new technologies
.

You may still have the impression that almost twenty years ago, the sales of the first terminal accounted for nearly 80% of the four terminals, and now, it is expected to fall below
60%.
This is mainly related to the change of people's drug consumption habits and the epidemic situation caused by the guidance of pharmaceutical policies, the rise of new terminals, and the development of new technologies
.

The first is policy
.
When the sales of drugs in the hospital market account for too large, it will definitely bring commercial bribery, medical insurance overdraft, medical resources run and other related problems
.
Therefore, in recent years, the pharmaceutical policy has spared no effort to push
drugs out of the standard.

The first is policy
.
When the sales of drugs in the hospital market account for too large, it will definitely bring commercial bribery, medical insurance overdraft, medical resources run and other related problems
.
Therefore, in recent years, the pharmaceutical policy has spared no effort to push
drugs out of the standard.

We review the pharmaceutical industry policies in the past two decades: "one product and two regulations", the prohibition of doctors' large prescriptions, the relevant provisions regulating the prescription of proprietary Chinese medicines in Western medicine, graded diagnosis and treatment, the top three circuit breakers in hospital drug sales, the "two-invoice system", the dual channel of medical insurance, the long prescription of chronic diseases, the collection and so on, all of which have led to the flow of drugs out
of the standard.

We review the pharmaceutical industry policies in the past two decades: "one product and two regulations", the prohibition of doctors' large prescriptions, the relevant provisions regulating the prescription of proprietary Chinese medicines in Western medicine, graded diagnosis and treatment, the top three circuit breakers in hospital drug sales, the "two-invoice system", the dual channel of medical insurance, the long prescription of chronic diseases, the collection and so on, all of which have led to the flow of drugs out
of the standard.

In particular, the collection policy strongly restricts the sales of drugs in the standard market from the life gate of
access.

In particular, the collection policy strongly restricts the sales of drugs in the standard market from the life gate of
access.

The second is the rise
of new terminals.
Twenty years ago, the number of pharmacies in China was not as large as it is now, and the primary medical institutions did not complete the layout
.
In particular, online sales of drugs are zero
.
Twenty years later, the situation is very different
.

The second is the rise
of new terminals.
Twenty years ago, the number of pharmacies in China was not as large as it is now, and the primary medical institutions did not complete the layout
.
In particular, online sales of drugs are zero
.
Twenty years later, the situation is very different
.

On the other hand, the national level is more and more cautious about the development of key public medical institutions, and from the health yearbook data released by the Health Commission, the number of public hospitals in China has not increased
significantly in recent years.
On the one hand, a number of state-owned enterprise hospitals were restructured; On the other hand, it may be related to the drawbacks caused by the excessive concentration of superior medical resources, and therefore there will be a hierarchical diagnosis and treatment policy
.

On the other hand, the national level is more and more cautious about the development of key public medical institutions, and from the health yearbook data released by the Health Commission, the number of public hospitals in China has not increased
significantly in recent years.
On the one hand, a number of state-owned enterprise hospitals were restructured; On the other hand, it may be related to the drawbacks caused by the excessive concentration of superior medical resources, and therefore there will be a hierarchical diagnosis and treatment policy
.

The third is that the development of new technologies has led to changes
in people's drug consumption habits.
The Chinese people have experienced the process
of online drug purchase by searching for small and chronic diseases, going to large hospitals, going to the nearest hospital, and searching for drugs online for minor and chronic diseases.
Especially with the development of technologies such as online consultation and online drug purchase, many people, especially many young people, have a small illness and are accustomed to searching for mobile phones first, and then placing orders
online.
These have led to the contraction
of the in-hospital market.

The third is that the development of new technologies has led to changes
in people's drug consumption habits.
The Chinese people have experienced the process
of online drug purchase by searching for small and chronic diseases, going to large hospitals, going to the nearest hospital, and searching for drugs online for minor and chronic diseases.
Especially with the development of technologies such as online consultation and online drug purchase, many people, especially many young people, have a small illness and are accustomed to searching for mobile phones first, and then placing orders
online.
These have led to the contraction
of the in-hospital market.

Finally, the epidemic has limited people's movements, and drug sales have been forced to shift to off-standard channels
such as online.
Since 2022, the epidemic has continued to have a great impact
on the pharmaceutical industry.

Finally, the epidemic has limited people's movements, and drug sales have been forced to shift to off-standard channels
such as online.
Since 2022, the epidemic has continued to have a great impact
on the pharmaceutical industry.

Since March, the two megacities of Shanghai and Beijing have experienced the epidemic, which has had a great impact on
pharmaceutical companies.

Since March, the two megacities of Shanghai and Beijing have experienced the epidemic, which has had a great impact on
pharmaceutical companies.

The main impacts include limited diagnosis and treatment work in medical institutions, limited patient medical treatment, limited movement of medical practitioners, limited sales of colds and other related products, and a year-on-year decline in the incidence of some diseases
.
These are also important reasons
for the development of pharmaceutical companies to the out-of-standard market, especially the development of online sales.

The main impacts include limited diagnosis and treatment work in medical institutions, limited patient medical treatment, limited movement of medical practitioners, limited sales of colds and other related products, and a year-on-year decline in the incidence of some diseases
.
These are also important reasons
for the development of pharmaceutical companies to the out-of-standard market, especially the development of online sales.

03 How to expand the out-of-standard market?

03 How to expand the out-of-standard market? 03 How to expand the out-of-standard market? 03 How to expand the out-of-standard market?

The first is the R&D end
.
It is necessary to develop some products
suitable for sale outside the standard market as soon as possible.
For example, OTC products, oral preparations, pharmaceutical and equipment combination products, functional health care products, etc
.

The first is the R&D end
.
It is necessary to develop some products
suitable for sale outside the standard market as soon as possible.
For example, OTC products, oral preparations, pharmaceutical and equipment combination products, functional health care products, etc
.

In the past, pharmaceutical companies liked to develop injections, mainly because injections were suitable for intra-standard market sales and high
profits.
After the collection, the most affected is the injection, even the high foreign companies, but also forced to participate in the national procurement of injections, the reason is because the injection can only be used in hospitals, and some regions even have restrictions on the drip of grass-roots medical institutions
.

In the past, pharmaceutical companies liked to develop injections, mainly because injections were suitable for intra-standard market sales and high
profits.
After the collection, the most affected is the injection, even the high foreign companies, but also forced to participate in the national procurement of injections, the reason is because the injection can only be used in hospitals, and some regions even have restrictions on the drip of grass-roots medical institutions
.

Developing some products suitable for sales outside the standard market, in addition to avoiding the impact of collection and procurement, is of great significance
for pharmaceutical companies to absorb surplus sales personnel.
The OTC market and the primary medical institution market have always been suitable for the tactics of the sea of people, and can absorb surplus sales personnel
.
In addition, because the off-standard market price is not affected by the collection, the profit is not smaller
than the in-standard market.

Developing some products suitable for sales outside the standard market, in addition to avoiding the impact of collection and procurement, is of great significance
for pharmaceutical companies to absorb surplus sales personnel.
The OTC market and the primary medical institution market have always been suitable for the tactics of the sea of people, and can absorb surplus sales personnel
.
In addition, because the off-standard market price is not affected by the collection, the profit is not smaller
than the in-standard market.

The company's sibling company previously purchased a generic drug approval document for the treatment of premature ejaculation in men, and was listed
during the epidemic.
Although the listing date is not timely, the author has always been optimistic about the sales
of this product.
In the future, this product is expected to solve the problem
of the basic salary of the company's personnel.

The company's sibling company previously purchased a generic drug approval document for the treatment of premature ejaculation in men, and was listed
during the epidemic.
Although the listing date is not timely, the author has always been optimistic about the sales
of this product.
In the future, this product is expected to solve the problem
of the basic salary of the company's personnel.

Recently, when I looked at generic drug projects, I also increased my attention to new products in this regard
.
Among them, some oral preparations developed in Japan are worth paying attention to
.

Recently, when I looked at generic drug projects, I also increased my attention to new products in this regard
.
Among them, some oral preparations developed in Japan are worth paying attention to
.

You may not have paid attention to the fact that many pharmaceutical companies have already begun the layout
of the off-standard market very early.
Di Bo Er Pu Er Tea Zhen is Tasly, Yunnan Baiyao toothpaste a year billion sales, China Resources Pharmaceutical Commercial in the sale of sprouted brown rice powder, the famous condom brand Jasper, in fact, Renfu Pharmaceutical.
.
.

You may not have paid attention to the fact that many pharmaceutical companies have already begun the layout
of the off-standard market very early.
Di Bo Er Pu Er Tea Zhen is Tasly, Yunnan Baiyao toothpaste a year billion sales, China Resources Pharmaceutical Commercial in the sale of sprouted brown rice powder, the famous condom brand Jasper, in fact, Renfu Pharmaceutical.
.
.

The second is to concentrate the company's resources to tilt
towards the out-of-standard market.
Comb through the company's existing product approvals, list the list of products suitable for sales outside the standard market for classification, and plan the key development products and potential products in the off-standard market; Build a non-hospital sales force; Change the traditional hospital sales practices, try to cooperate with new media, online marketing companies and so on
.

The second is to concentrate the company's resources to tilt
towards the out-of-standard market.
Comb through the company's existing product approvals, list the list of products suitable for sales outside the standard market for classification, and plan the key development products and potential products in the off-standard market; Build a non-hospital sales force; Change the traditional hospital sales practices, try to cooperate with new media, online marketing companies and so on
.

In short, due to the industry policy orientation, intensive collection and the impact of the epidemic, it is urgent for generic drug companies to sell in the non-standard market
.
Relevant enterprises need to have a sense of urgency to seize the day, accelerate the pace of transformation, launch products outside the standard market as soon as possible, form a sales team outside the standard, and achieve the profitability
of the market outside the standard.
Doing this may mean that the company has survived the difficult period
.
On the contrary, it is not optimistic
.

In short, due to the industry policy orientation, intensive collection and the impact of the epidemic, it is urgent for generic drug companies to sell in the non-standard market
.
Relevant enterprises need to have a sense of urgency to seize the day, accelerate the pace of transformation, launch products outside the standard market as soon as possible, form a sales team outside the standard, and achieve the profitability
of the market outside the standard.
Doing this may mean that the company has survived the difficult period
.
On the contrary, it is not optimistic
.